Abstract #1928
            In vivo imaging of Tau pathology using Multi-Parametric Quantitative MRI
                      Jack A Wells                     1                    , James M O'Callaghan                     1                    , 						Holly E Holmes                     1                    , Nicholas M Powell                     1                    , 						Bernard Siow                     1                    , F Torrealdea                     2                    , 						Marilena Rega                     2                    , Ozama Ismail                     1                    , 						Simon Walker-Samuel                     1                    , Xavier Golay                     2                    , 						Simon Richardson                     1                    , Adam J Schwarz                     3                    , 						Michael J O'Neil                     4                    , Emily C Collins                     3                    , 						Niall Colgan                     1                    , and Mark F Lythgoe                     1          
            
            1
           
           Centre for Advanced Biomedical Imaging, UCL, 
						London, London, United Kingdom,
           
            2
           
           Institute 
						of Neurology, UCL, London, United Kingdom,
           
            3
           
           Lilly 
						Corporate Centre, Eli Lilly & Co. Ltd, Indianapolis, 
						United States,
           
            4
           
           Eli 
						Lilly & Co. Ltd Erl Wood Manor, Windlesham, Surrey, 
						United Kingdom
          
            
          In this study, we target diverse and specific components 
						of tau pathology by applying multi-parametric MRI to the 
						rTg4510 model of Alzheimers disease. We investigate how 
						elevated tau expression affects: i) cerebral blood flow 
						using arterial spin labelling ii) chemical exchange 
						saturation transfer iii) brain glucose uptake using 
						gluco-CEST iv) diffusion tensor imaging and v) brain 
						atrophy using tensor based morphometry. Each technique 
						can unambiguously discriminate tau pathology from 
						healthy control subjects in selective white and grey 
						matter regions, providing a platform for the 
						longitudinal assessment of experimental treatments using 
						non-invasive imaging techniques.
         
				
					How to access this content:
					For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
					After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
					After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
					Click here for more information on becoming a member.